INDP · Indaptus Therapeutics, Inc.
$1.14
-0.02 (-1.72%)
At close · Aug 28
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on its current operating plans and available financial resources, the Company believes that it has sufficient liquidity to fund its planned operations and investment activities through June 30, 2027. The Company may further strengthen its capital position through additional public or private equity or debt financings as appropriate to support its strategic objectives and long-term development. As a result of these uncertainties, there is substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$151.90M
Shares
133.24M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2025-06-20 | New | Pharmaceuticals | $5,000,000 | $2,314,800 | 06c |
| 2025-01-22 | New | Pharmaceuticals | $2,246,500 | $2,246,500 | 06b |
| 2024-12-06 | New | Pharmaceuticals | $227,127 | $227,127 | 06b |
| 2024-10-04 | Amendment | Pharmaceuticals | $205,480 | $205,480 | 06b |
| 2024-08-22 | New | Pharmaceuticals | $205,480 | $205,480 | 06b |
| 2021-08-05 | New | Pharmaceuticals | $30,000,000 | $30,000,000 | 06b |
Showing 1–6 of 6 filings